Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bernhard Doleschal
Observed names:
B Doleschal,
B. Doleschal,
Doleschal, Bernhard
Institutions:
Johannes Kepler University of Linz,
Ordensklinikum Linz Barmherzige Schwestern
Observed institutions:
Johannes Kepler University of Linz,
University of Graz,
Medical University of Graz,
Ordensklinikum Linz Barmherzige Schwestern,
Kepler Universitätsklinikum,
Krankenhaus der Elisabethinen,
Medical University of Vienna
show all 7
ORCID:
0009-0004-4813-4435
Observed ORCID:
0009-0004-4813-4435
OpenAlex ID:
A5011711845
Novel pyrazole compounds for pharmacological discrimination between receptor‐operated and store‐operated Ca 2+ entry pathways
2012
·
H Schleifer
, B Doleschal
, et al.
·
British Journal of Pharmacology
·
228
PDF
Bile acids induce arrhythmias in human atrial myocardium—implications for altered serum bile acid composition in patients with atrial fibrillation
2013
·
Peter P Rainer
, Uwe Primessnig
, et al.
·
Heart
·
105
TRPC3 contributes to regulation of cardiac contractility and arrhythmogenesis by dynamic interaction with NCX1
2015
·
B. Doleschal
, U. Primessnig
, et al.
·
Cardiovascular Research
·
97
PDF
Sunitinib causes dose‐dependent negative functional effects on myocardium and cardiomyocytes
2012
·
Peter P. Rainer
, Bernhard Doleschal
, et al.
·
British Journal of Urology
·
53
Current concepts of anti-EGFR targeting in metastatic colorectal cancer
2022
·
Bernhard Doleschal
, Andreas Petzer
, et al.
·
Frontiers in Oncology
·
40
PDF
Immunotherapy for Microsatellite-Stable Metastatic Colorectal Cancer: Can we close the Gap between Potential and Practice?
2024
·
Marwa Abdel Hamid
, Lorenz M. Pammer
, et al.
·
Current Oncology Reports
·
36
PDF
Real world evidence reveals improved survival outcomes in biliary tract cancer through molecular matched targeted treatment
2023
·
Bernhard Doleschal
, Hossein Taghizadeh
, et al.
·
Scientific Reports
·
30
PDF
The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML): A representative and useful real-life data source for further biomedical research
2019
·
Klaus Geissler
, Eva Jäger
, et al.
·
Wiener klinische Wochenschrift
·
29
PDF
cAMP‐ and Ca2+/calmodulin‐dependent protein kinases mediate inotropic, lusitropic and arrhythmogenic effects of urocortin 2 in mouse ventricular myocytes
2010
·
Li‐Zhen Yang
, Jens Kockskämper
, et al.
·
British Journal of Pharmacology
·
29
PDF
Disseminated Histoplasmosis: A Challenging Differential Diagnostic Consideration for Suspected Malignant Lesions in the Digestive Tract
2016
·
Bernhard Doleschal
, Therese Rödhammer
, et al.
·
Case Reports in Gastroenterology
·
21
Inhibition of Orai1-mediated Ca 2+ entry is a key mechanism of the antiproliferative action of sirolimus in human arterial smooth muscle
2013
·
Sarah König
, Sara Browne
, et al.
·
American Journal of Physiology-Heart and Circulatory Physiology
·
20
Understanding homologous recombination repair deficiency in biliary tract cancers: clinical implications and correlation with platinum sensitivity
2024
·
I.-A. Mavroeidi
, J. Burghofer
, et al.
·
ESMO Open
·
14
PDF
Circulating Tumor DNA (ctDNA) Dynamics Predict Early Response to Treatment in Metastasized Gastroesophageal Cancer (mGEC) After 2 Weeks of Systemic Treatment
2024
·
Stefan Tatalovic
, Bernhard Doleschal
, et al.
·
Cancers
·
10
Clinical practice and implications of biomarker testing in biliary tract cancer: An observational study
2025
·
Sabrina Welland
, Ann-Kristin Zöller
, et al.
·
JHEP Reports
·
9
PDF
Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data
2024
·
Patrick Reimann
, Ilektra-Antonia Mavroeidi
, et al.
·
Cancer Immunology Immunotherapy
·
9
PDF
NALIRIFOX in the treatment of metastatic pancreatic ductal adenocarcinoma: an exploratory analysis of real-world data
2025
·
A. Reichinger
, A. Friedrich
, et al.
·
ESMO Open
·
8
Exceptional sustained long-term complete response to Tepotinib in a MET-amplified advanced intrahepatic biliary tract cancer failing Durvalumab plus Cisplatin and Gemcitabine
2024
·
Andreas Reichinger
, Leo Essl
, et al.
·
The Oncologist
·
8
Bevacizumab mitigates codon-specific effects of trifluridine/tipiracil on efficacy outcome parameters in metastatic colorectal cancer
2023
·
B. Doleschal
, H. Taghizadeh
, et al.
·
ESMO Open
·
7
Response prediction by mutation- or methylation-specific detection of ctDNA dynamics in pretreated metastatic colorectal cancer
2023
·
Bernhard Doleschal
, Patrick Kirchweger
, et al.
·
Therapeutic Advances in Medical Oncology
·
6
Unraveling (K)RAS in pancreatic ductal adenocarcinoma
2024
·
Bernhard Doleschal
·
memo - Magazine of European Medical Oncology
·
5
PDF
Survival Outcome in Early-Onset Metastatic Colorectal Cancer: A Multicenter-Matched Pair Analysis
2023
·
Bernhard Doleschal
, Dora Niedersüß-Beke
, et al.
·
Oncology
·
5
Taxan-associated nail toxicity
2017
·
Bernhard Doleschal
, Andreas Petzer
, et al.
·
BMJ Case Reports
·
5
PDF
Clinical Outcome in Patients with Carcinoma of the Esophagogastric Junction Treated with Neoadjuvant Radiochemotherapy or Perioperative Chemotherapy: A Two-Center Retrospective Analysis
2020
·
Helwig Valentin Wundsam
, Bernhard Doleschal
, et al.
·
Oncology
·
4
PDF
Clinical outcomes of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil or regorafenib in metastatic colorectal cancer: a multicenter cohort study
2026
·
F. Moik
, F. Huemer
, et al.
·
ESMO Open
·
2
Personalized decision making of neoadjuvant chemotherapy vs. upfront surgery in pancreatic cancer by a simple blood collection?
2024
·
Patrick Kirchweger
, Bernhard Doleschal
, et al.
·
memo - Magazine of European Medical Oncology
·
2
PDF
Show more works
View as search
Works count:
65
Citation count:
788
H-index:
12
I10-index:
13
Year
Topic
Type